All Neuroscience articles – Page 5
-
ResearchMolecular container mops up tricaine to reverse anaesthesia in fish
Scientists use cucurbit[7]uril to rouse zebrafish from anaesthesic coma
-
Business
Actavis plan to thwart generics blocked
Company prevented from withdrawing original formulation of Alzheimer’s drug to force patients onto extended release version and extend patent exclusivity
-
ResearchCoated nanoparticles show Alzheimer's promise
Gold nanoparticles functionalised with amino acid polymer inhibit the growth of amyloid fibres associated with neurodegenerative disease
-
NewsRenewed focus on dementia checked by drug challenges
‘Ticking time bomb’ of global neurodegenerative disease burden will be difficult to defuse
-
NewsFears over pesticide link to foetal brain harm
European food safety body lowers exposure levels for two neonicotinoid insecticides
-
News'Scientific censorship' hamstringing psychoactive drug research
New treatments for psychological disorders are being held back by government controls on recreational drugs
-
NewsDrug restrictions delay magic mushroom trial
Illegal drugs red tape holding up clinical research on antidepressant activity of psilocybin
-
-
Business
Alzheimer's drug flops in Phase III
Solanezumab from Eli Lilly missed the cognitive and functional primary endpoints of the trials
-
Business
Bapineuzunab dropped
Development for the Alzheimer’s treatment stopped after clinical tests
-
-
FeatureBreaking through the barrier
Getting drug molecules into the brain means crossing the defensive blood-brain barrier. Anthony King investigates how chemists are infiltrating the brain's fortress
-
- Previous Page
- Page1
- Page2
- Page3
- Page4
- Page5
- Next Page